AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
229,00 $ ↑6,18 (2,77%)
2026-06-05
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionCahaba Wealth Management, Inc.
Latest Disclosed Ownership3,617 shares
Latest Disclosed Value $ 786,722
Cahaba Wealth Management, Inc. reports 0.36% increase in ownership of 0QCV / AbbVie Inc.

On April 29, 2026 - Cahaba Wealth Management, Inc. filed a 13F-HR form disclosing ownership of 3,617 shares of AbbVie Inc. (GB:0QCV) valued at $783,153 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 3,604 shares of AbbVie Inc.. This represents a change in shares of 0.36% during the quarter. The current value of the position is $828,293 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ABBVIE COM 00287Y109 3,617 13 0.36 787 -4.50 0.0534
2026-01-07 2025-12-31 13F ABBVIE COM 00287Y109 3,604 90 2.56 824 1.23 0.0573
2025-10-17 2025-09-30 13F ABBVIE COM 00287Y109 3,514 -10 -0.28 814 24.31 0.0589
2025-07-16 2025-06-30 13F ABBVIE COM 00287Y109 3,524 70 2.03 654 -9.54 0.0508
2025-05-01 2025-03-31 13F ABBVIE COM 00287Y109 3,454 -46 -1.31 724 16.43 0.0599
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 3,500 233 7.13 622 -3.72 0.0515
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 3,267 9 0.28 645 15.59 0.0532
2024-08-05 2024-06-30 13F ABBVIE COM 00287Y109 3,258 10 0.31 559 -5.58 0.0493
2024-04-22 2024-03-31 13F ABBVIE COM 00287Y109 3,248 -4 -0.12 591 17.50 0.0538
2024-01-23 2023-12-31 13F ABBVIE COM 00287Y109 3,252 -796 -19.66 504 -16.58 0.0500
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 4,048 -183 -4.33 603 5.98 0.0665
2023-07-26 2023-06-30 13F ABBVIE COM 00287Y109 4,231 1,736 69.58 570 43.32 0.0616
2023-05-04 2023-03-31 13F ABBVIE COM 00287Y109 2,495 7 0.28 398 -1.24 0.0455
2023-01-30 2022-12-31 13F ABBVIE COM 00287Y109 2,488 -46 -1.82 402 18.24 0.0499
2022-10-19 2022-09-30 13F ABBVIE INC COM COM 00287Y109 2,534 -3 -0.12 340 -12.37 0.0470
2022-07-19 2022-06-30 13F ABBVIE INC COM COM 00287Y109 2,537 10 0.40 388 4.58 0.0554
2022-05-05 2022-03-31 13F ABBVIE INC COM COM 00287Y109 2,527 757 42.77 371 54.58 0.0509
2022-02-01 2021-12-31 13F ABBVIE INC COM COM 00287Y109 1,770 1,770 240 0.0318
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.